National Webinar - Keeping drug plans sustainable through unparalleled growth

January 26, 2017 1:00 PM to 2:00 PMOnline - Eastern Time Zone
Area of Interest: Benefits Format: Web
An update on the latest drug spending trends
Fees and Registration
Membership Types Regular Price Plan Sponsor Price
Regular membership $0.00 CDN $0.00 CDN
Plan Sponsor Individual Membership $0.00 CDN $0.00 CDN
Associate $0.00 CDN $0.00 CDN
Student $0.00 CDN -
Non Member $90.00 CDN $65.00 CDN
Event: ‘Event Full’
Cancellation Policy
CE credits are offered in partnership with La Chambre de sécurité financière, The Institute, Insurance council of Manitoba, Saskatchewan, Alberta and BC
Session Description 

In this session Barbara will update us on the latest drug spending trends – what new drugs are driving drug plan spending, what new market forces are in place and what can plan sponsors do to keep their drug plans affordable and sustainable. 
Learning objectives

At the end of the session you will

  • Understand drug plan trends and what is behind them
  • Understand what options are available to plan sponsors to manage drug spending while balancing the health needs of plan members.
Who should attend this session 
  1. Employers that offer drug plans
  2. insurers
  3. Consultants and brokers
  4. Pharma companies
 
 About the speaker 
 

Barbara Martinez 
Practice Leader, Benefits Solutions, 
The Great-West Life Assurance Company
Barbara A. Martinez is the National Practice Leader, Drug Benefits Solutions in the Toronto Group Sales office of Great-West Life Assurance Company. Barbara provides support to Great-West Life Group Sales Offices across Canada on our prescription drug management initiatives. She plays a key role in supporting plan advisors and their clients on Great-West Life drug solutions products.
Barb joined Great-West Life in November of 2012 and is ideally suited to this role. She comes to Great-West Life with 10 years’ experience at Mercer, where she lead the Canadian drug benefits consulting team. She is also well known as a regular speaker at industry forums and commentator on employer drug programs.
Barbara has in-depth knowledge of the prescription drug, regulatory and drug approval process in Canada from both a government and private drug plan perspective. Her past experience includes 13 years of working in the pharmaceutical industry. Her main responsibilities were sales & marketing as well as government and professional affairs.